ASBP Aspire BioPharma, Inc.
Company Analysis
Latest News
🔴 Aspire BioPharma, Inc. makes sharp 11.1% drop
ASBP is trading at $5.85, down 11.1% versus the comparison close of $6.58 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 Aspire BioPharma, Inc. is trading 6.2% down today after a sharp multi-session rally
Aspire BioPharma, Inc. is trading 6.2% down at $6.17 in pre-market sessions as the stock undergoes consolidation following a high-momentum week. • The price...
🔴 Aspire BioPharma, Inc. is trading 7.3% down today as it pulls back from recent gains with no clear catalyst
Aspire BioPharma, Inc. is trading at $6.10 (7.3%) down in after-hours trading, pulling back after several strong up days in the regular session. • The move...
🔴 Aspire BioPharma, Inc. makes sharp 10.2% drop
ASBP is trading at $5.71, down 10.2% versus the comparison close of $6.36 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Aspire BioPharma, Inc. is trading 5.4% down today on profit-taking after a recent run-up
Aspire BioPharma, Inc. is trading 5.4% down at $6.02 today as the stock pulls back following a sharp multi-day rally. • The move appears to be driven by...
🟢 Aspire BioPharma, Inc. makes sharp 11.1% jump
ASBP is trading at $6.88, up 11.1% versus the comparison close of $6.19 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Aspire BioPharma, Inc. is trading 7.8% up today on continued high-volatility momentum
Aspire BioPharma, Inc. is trading 7.8% up at $6.67 on continued high-volatility momentum following a period of recent weakness. • The stock is extending a...
🟢 Aspire BioPharma, Inc. makes sharp 11.1% jump
ASBP is trading at $6.28, up 11.1% versus the comparison close of $5.65 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Aspire BioPharma, Inc. is trading 5.7% up today as it rebounds from a sharp selloff over its $30M acquisition deal
Aspire BioPharma, Inc. is trading at $5.97 (5.7% up) today as shares stage a technical recovery following a sharp selloff triggered by its recent acquisition...